512 JOURNAL OF COSMETIC SCIENCE
regression method with target criteria of decimal reduction times [D-values] of ≤4 hours
for pathogens, ≤28 hours for nonpathogenic bacteria, yeast and mold, and bactericidal/
bacteriostatic for Bacillus spores), to the relaxed (e.g., PCPC criteria of at least a 3-log
reduction of bacteria in 7 days), and to the very relaxed (e.g., USP criteria of at least a
2-log reduction of bacteria in 14 days).12,13,163 Sooner or later, companies that have products
that just meet these relaxed acceptance criteria will experience instances of microbial
contamination that result in destruction of batches, recovery of merchandise after
shipment to the trade, or product recalls, even though these companies adhere to GMPs
in every aspect of their manufacturing process. The root cause of the problem often may
be inadequate preservative systems.163
Some companies classify different products as “sensitive” or “low risk,” “medium risk,” or
“high risk,” depending on their experience with microbial contamination.163 This product
classification is inappropriate because manufacturers should not blame products for being
sensitive or high risk when, in fact, the problem is inadequate preservation. The sensitive
products should be reformulated, so they have adequate preservative systems.
A basic requirement for the preservation of aqueous products is that the preservative system
must kill microorganisms fast enough to prevent their adaptation to the preservative
system, because adapted microorganisms are then able to grow in the product. As noted
above, Wolven and Levinstein8 performed challenge tests and concluded that “regardless of
the method employed to demonstrate preservative efficacy, no growth should occur after
seven days.” Orth, Delgadillo and Dumatol determined the maximum allowable rates of
death (i.e., D-values) needed to prevent adaptation of P. aeruginosa, E. coli, and Burkholderia
cepacia were around 30 hours, which is about a 6-log reduction in 7 days.164 These
acceptance criteria may be difficult to achieve in some formulations that do not contain
formaldehyde or formaldehyde donors, especially for spore-formers like Bacillus spp. and
molds. Not meeting target criteria may be acceptable if further testing demonstrates the
formula kills vegetative cells and is bacteriostatic/fungistatic for spores. It was proposed that
additional studies are needed to have enough data to establish the minimum preservative
acceptance criteria requirements for aqueous products.165 It is recommended that cosmetic
manufacturers address this issue.
CROSS-RESISTANCE OF PRESERVATIVES WITH ANTIBIOTICS
In 1998, McMurry, Oethinger and Levy reported that Triclosan interfered with the
biosynthesis of fatty acids by blocking enoyl reductase in E. coli.166 This work showed that
Triclosan—a biocide— may act like an antibiotic that interferes with a single cellular
process (i.e., lipid biosynthesis). Their work suggested that Triclosan resistance could be
part of a larger problem of antimicrobial resistance (AMR) and that overuse of Triclosan in
consumer products may increase this problem.
This was alarming because many people in the cosmetic industry were concerned that there
may be a connection between use of preservatives/biocides and AMR. Many preservatives
and other chemicals used in cosmetics and OTC drugs have been found to induce multiple-
antibiotic resistance. It was reported that salicylate and benzoate may induce multiple-
antibiotic resistance in a number of bacteria including B. cepacia, E. coli, Klebsiella pneumonia,
and S. aureus.167-171 Cohen et al. observed a connection between phenotypic antibiotic
resistance and induction of the multiple-antibiotic resistance (mar) operon, salicylate,
513 Evolution and Challenges of Sustainability
acetylsalicylate, acetaminophen, sodium benzoate, and cinnamate induced expression of
the marRAB operon of E. coli.169 This is important because the marRAB operon responds to
several compounds including tetracycline and chloramphenicol.172 McDonnell and Russell
indicated that plasmid-mediated efflux pumps were responsible for resistance to many
antibiotics and biocides.173
The American Society for Microbiology has classified AMR to be a top priority.174 In 2023,
Darby et al. indicated that antibiotic resistance is a global health emergency, and resistance
has been detected to all antibiotics currently in clinical use.175 Products should not contain
ingredients that cause AMR. Products with such ingredients may cause AMR when released
into the environment (i.e., when washed off the skin during bathing), and application of
such products onto skin may cause AMR in some members of the skin microbiome—
neither of these outcomes is sustainable. Although over-prescription of antibiotics and use
of antibiotics in agriculture and raising farm animals is known, the cosmetic industry
may unwittingly be contributing to the problem of AMR. Orth stated that cosmetic and
drug manufacturers should have programs to ensure that their products will not encourage
the development of drug-resistant microorganisms.176 It is recommended that cosmetic
manufacturers address this issue. This will require additional risk assessment and testing,
but it will help identify ingredients that cause AMR so that they can be eliminated—this
is needed for products to be sustainable.
SUSTAINABLE PRODUCTS THAT WORK WITH THE SKIN MICROBIOME
Sustainability can be achieved through activities that do not have adverse effects on
the environment or cause loss of biodiversity, which is necessary for living populations
to survive stressful changes in their environment. The cosmetic and drug industries are
beginning to address sustainability by using ingredients from renewable resources and
by replacing packaging materials that are not biodegradable (e.g., plastic) with alternative
materials. Ingredients, including preservatives and multifunctional ingredients, may be
sourced from companies committed to address sustainability, and products made with
such ingredients may have negligible carbon footprints or minimal effects on biodiversity
however, there may be issues related to the effect of preservatives and multifunctional
ingredients in products on the skin/skin microbiome ecosystem.
Spragge et al. observed that diversity involving “key species” contributed to colonization
resistance to prevent pathogen infection in the GI tract.161 It is believed that a similar
situation may occur on skin, so it is important that preservatives, multifunctional
ingredients that have antimicrobial action, and other ingredients, do not adversely affect
skin microbiome diversity. Although it has been estimated that Cutibacterium, Staphylococcus,
and Corynebacterium genera constitute up to 80% of the entire skin microbiome,73 we do
not know if bacteria in these genera or the Malassezia spp. on the scalp and upper body
constitute the key species necessary for survival and maintenance of homeostasis when
the microenvironment of skin is changed following changes in the environment or use
of cosmetic products. It is recommended that studies be conducted to determine the key
species in various skin sites of healthy individuals so that these microorganisms may then be
used as biomarkers to assess the effect of product use on the skin microbiome in these sites.
Products that have no adverse effects on these biomarkers or the healthy skin microbiome
are sustainable because they will help prevent dysbiosis and maintain homeostasis.
Previous Page Next Page